Cell of origin associated classification of B-cell malignancies by gene signatures of the normal B-cell hierarchy

Hans Erik Johnsen(Herlev Hospital), Kim Steve Bergkvist(Chr. Hansen (Denmark)), Alexander Schmitz(Chr. Hansen (Denmark)), Julie Støve Bødker(Chr. Hansen (Denmark)), Martin Bøgsted(Chr. Hansen (Denmark)), Preben Johansen(Chr. Hansen (Denmark)), Michael Gaihede(Chr. Hansen (Denmark)), Martin Agge Nørgaard, Marie-Louise M. Grønholdt, John Bæch(Aalborg University Hospital), Frank Svendsen Jensen, Steen Møller Hansen(Aalborg University Hospital), Karen Dybkær(Aalborg University Hospital), Malene Krag Kjeldsen(Chr. Hansen (Denmark))

Leukemia & lymphoma/Leukemia and lymphoma

September 3, 2013

10.3109/10428194.2013.839785

Cited by 17

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

|Blood|2009|390

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

|Leukemia|2015|256